2023
|
Invention
|
Methods and compositions for reducing body fat and adipocytes.
Provided are methods of reducing ... |
|
Invention
|
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat.
Described h... |
2021
|
Invention
|
Compositions and methods for topical delivery of prostaglandins to subcutaneous fat.
Described h... |
|
Invention
|
Compositions and methods for reducing body fat.
The present invention relates to compositions, s... |
2017
|
Invention
|
Compositions and methods for topical delivery of prostaglandins to subcutaneous fat. Described he... |
|
Invention
|
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat. Described he... |
|
Invention
|
Compositions and methods for reducing body fat. The present invention relates to compositions, su... |
2016
|
Invention
|
Methods and compositions for treating metabolic syndrome. Provided are methods, compositions, sys... |
2015
|
Invention
|
Methods for reducing body fat using tafluprost and analogs thereof. Provided are methods of reduc... |
|
Invention
|
Topical dosage regimen. Described herein is a novel dosage regimen, and related uses and methods,... |
|
Invention
|
Topical compositions comprising a thiazolidinedione. Provided herein are compositions comprising ... |
|
Invention
|
Methods for topical delivery of prostaglandins to subcutaneous fat. Described herein are composit... |
2014
|
Invention
|
Compositions for topical delivery of prostaglandins to subcutaneous fat. Described herein are com... |
|
Invention
|
Methods for reducing body fat. Provided are methods, compositions, systems, and kits for treating... |
|
Invention
|
Methods and compositions for reducing body fat and adipocytes. Provided are methods and compositi... |
2013
|
Invention
|
Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcut... |
|
Invention
|
Methods and compositions for locally increasing body fat. Provided are methods for increasing fat... |
|
Invention
|
Lactol and acetal intermediates for making prostaglandins. 11 is optionally substituted alkyl, op... |
|
Invention
|
Methods and compositions for reducing body fat and adipocytes. Provided are methods of reducing b... |
2012
|
Invention
|
Tafluprost and analogs thereof for reducing fat. Provided are methods of reducing body fat in a s... |
|
Invention
|
Methods and compositions for treating metabolic syndrome. 2, Z, X, A and B are defined herein.
|
|
Invention
|
Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia. Provided a... |
|
Invention
|
Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia. Prov... |
|
Invention
|
Use of bimatoprost free acid administered to the skin to reduce adipose tissue. Provided a... |